# CIMG Inc. > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/en/companies/CIMG Inc.). ## Overview CIMG Inc. is a Nevada-incorporated, Nasdaq-listed company that has shifted its identity from NuZee, Inc. to a broader digital marketing, distribution, and consumer-products platform. The company says it is using artificial intelligence, and in some cases blockchain-related technologies, to support brand management, user growth, and online sales. In 2024-2025 it also expanded into Asia-focused distribution and added Maca-infused food and beverage products, while introducing new revenue streams such as Computing Power Product Series and the Homology of Medicine and Food Series. The business is still in transition and appears to be building a more diversified consumer and technology-linked portfolio around online commerce, third-party distribution, and product commercialization. ## Products & services • Maca Series consumer food and beverage products • Homology of Medicine and Food Series products • Computing Power Product Series • Online sales and distribution platform • Digital marketing and brand management services • AI-enabled natural language search commerce tools - **Maca Series products** (45%) — Maca-infused food and beverage products sold through the company's distribution and online channels. - **Homology of Medicine and Food Series** (17%) — Functional consumer products positioned at the intersection of food and wellness. - **Computing Power Product Series** (10%) — Newly introduced technology-linked product stream tied to computing power offerings. - **Digital marketing and brand services** (8%) — Services and capabilities used to support user growth, brand management, and online commercialization. - **Online distribution platform** (20%) — E-commerce and channel infrastructure used to market and distribute consumer products in Asia. - Maca Series consumer food and beverage products - Homology of Medicine and Food Series products - Computing Power Product Series - Online sales and distribution platform - Digital marketing and brand management services - AI-enabled natural language search commerce tools ## Customers CIMG's customers appear to be concentrated in a small number of commercial counterparties rather than a broad retail base. The company disclosed that its two largest customers accounted for about 96% of fiscal 2025 revenue, indicating that a handful of buyers or channel partners are critical to sales volume. The business also relies on brokers, distributors, common carriers, retailers, and third-party manufacturing partners to move products through its network, so customer demand is closely tied to channel execution. End demand is centered on consumer food and beverage products, especially Maca Series offerings, and on newer product lines that the company is trying to commercialize. - **Large concentrated commercial customers** (primary) — A very small number of customers generate most revenue and likely purchase in bulk or through distribution agreements. - **Distributors and brokers** (primary) — Buy or place products into downstream channels and are important because they determine market access and product turnover. - **Retailers and common carriers** (secondary) — Handle last-mile availability and logistics for the company's consumer products, affecting sell-through and service levels. - **Asia-focused consumer end markets** (secondary) — Consumers of Maca-infused and functional food-and-beverage products who buy for wellness, novelty, or brand appeal. - **Technology and digital commerce counterparties** (emerging) — Customers or partners tied to the company's AI, blockchain, and computing-power initiatives as it broadens its revenue base. - Two large customers account for most revenue and drive near-term sales volume - Channel partners buy products for resale or distribution into consumer markets - Retailers and distributors matter because they control shelf access and reach - Third-party manufacturers are critical counterparties for product supply continuity - Consumers of Maca and wellness-oriented products are the end-market demand base - Commercial buyers likely value product novelty, margin, and supply reliability ## Geography CIMG is a U.S.-incorporated company listed on Nasdaq, but its commercial focus has increasingly shifted toward Asia. Management says it is expanding sales and distribution channels in Asia to cover a wider range of consumer food and beverage products, and it has also described an online sales platform designed to support that expansion. The company previously sold its Korean subsidiaries in 2024, which suggests its operating footprint has been in flux as it repositions the business. Because the business depends on third-party logistics, manufacturing, and distribution partners, geography matters not only for demand but also for supply-chain execution and regulatory exposure. - Headquartered in the United States and listed on Nasdaq - Commercial expansion is focused on Asia for consumer product distribution - Korea was previously part of the structure, but subsidiaries were sold in 2024 - Online sales platform supports cross-border reach and channel expansion - Third-party manufacturing and logistics create operational exposure across markets ## Strategy CIMG's stated strategy is to transform from a legacy consumer business into a broader digital marketing and distribution platform supported by AI and, where appropriate, blockchain-related technologies. A key priority is expanding sales and distribution channels in Asia, particularly for Maca-infused food and beverage products and related consumer offerings. The company is also trying to diversify beyond a narrow product set by introducing new revenue streams such as Computing Power Product Series and the Homology of Medicine and Food Series. This strategy matters because the company is highly concentrated in a few products, customers, and suppliers, so diversification is central to reducing execution risk and improving bargaining power. - **Diversify product revenue** (short-term) — The company is highly concentrated in Maca Series and related products, so new offerings are needed to reduce single-product dependence. - **Expand Asia sales and distribution** (medium-term) — Asia is the main growth geography disclosed in the reports and is central to scaling consumer product sales. - **Improve digital commerce capabilities** (medium-term) — AI-enabled search and digital marketing are intended to improve user acquisition, brand visibility, and conversion. - **Reduce supply-chain and channel dependence** (medium-term) — The business relies heavily on third-party manufacturers, distributors, and retailers, so resilience depends on partner stability. - Expand Asia distribution to broaden the addressable market - Use an online sales platform and natural language search to improve discovery - Commercialize Maca Series products and adjacent wellness offerings - Develop new revenue streams to reduce dependence on one product family - Apply AI and blockchain-related tools to support user growth and brand management - Strengthen third-party distribution and manufacturing relationships ## Risks CIMG faces substantial concentration risk because a very small number of customers and suppliers account for most of its revenue and purchases. The company also depends on third-party brokers, distributors, common carriers, and manufacturers, so operational performance can be disrupted by partner failures, pricing pressure, or supply interruptions. Its newer initiatives in AI, computing power, and digital assets add technology, cybersecurity, valuation, and regulatory uncertainty on top of the core consumer-products risks. More broadly, the business is exposed to changing consumer preferences, competition in wellness products, and cross-border execution risk as it expands in Asia. - **Customer concentration** [critical] — Two customers represented about 96% of fiscal 2025 revenue, so the loss or reduction of either customer would materially affect sales and cash flow. - **Supplier concentration** [critical] — Two suppliers accounted for 96.76% of purchases, creating a major risk of shortages, delays, and pricing pressure. - **Product concentration in Maca Series** [high] — A large share of revenue comes from a narrow product set, so demand weakness or reputational issues would have an outsized impact. - **Third-party distribution and manufacturing dependence** [high] — The company relies on external brokers, carriers, retailers, and manufacturers, so partner underperformance can interrupt sales. - **Digital asset and AI-related uncertainty** [medium] — Bitcoin holdings and AI-related initiatives introduce volatility, custody, cybersecurity, and regulatory risks. - Customer concentration could sharply reduce revenue if one major buyer leaves - Supplier concentration can disrupt production and raise input costs - Third-party logistics and distribution failures can interrupt product availability - Maca Series demand risk is high because the business is concentrated in that line - AI and digital asset exposure adds regulatory, custody, and valuation uncertainty - Cross-border expansion in Asia increases execution and compliance risk - Consumer preference shifts or competition could weaken product acceptance ## Accounting CIMG reports under U.S. GAAP and appears to rely on significant management judgment because the business is still evolving and includes new product and technology initiatives. Revenue recognition may be affected by the timing of product delivery, distributor arrangements, and any contract terms with concentrated customers, so investors should watch for cut-off and channel-related issues. The company also disclosed Bitcoin holdings from time to time, which can create fair value, custody, and impairment/valuation considerations depending on the accounting treatment and the nature of the financing activity. In addition, the business has meaningful exposure to estimates around inventory, supplier commitments, and potential allowances or write-downs if product demand or supply-chain conditions change. - **Revenue recognition timing** — Reported revenue and quarterly comparability - **Digital asset valuation** — Other income/expense and balance sheet volatility - **Inventory valuation and obsolescence** — Gross margin and working capital - **Estimates and assumptions under US GAAP** — Earnings quality and comparability - Revenue recognition depends on delivery terms and customer contract structure - Concentrated customer arrangements can affect timing and collectability judgments - Bitcoin and other digital assets create valuation and custody accounting issues - Inventory valuation matters if Maca or new products slow in sell-through - New product launches may require estimates for returns, obsolescence, or reserves - US GAAP estimates are important because the business model is still changing --- *Last updated: 2026-08-11T04:46:25.947499+00:00*